Fairfax acquires New Zealand’s Tower Insurance in all-cash deal
Canada-based Fairfax Financial Holdings, a property and casualty re/insurer, has agreed to acquire New Zealand-based general insurer Tower for an all-cash deal.
Fairfax will acquire 100 percent of Tower shares at NZ$1.17 ($0.84) per share for an aggregate acquisition cost of NZ$197 million ($144 million). The price per share represents a premium of 48 percent to
Tower's closing share price on 8 February and a 47 percent premium to Tower's three-month volume weighted average price (VWAP).
"The acquisition of Tower will provide us with an immediate significant presence, with a strong management team, which will continue to be led by Richard Harding, in a market where Fairfax currently has limited exposure,” said Prem Watsa, chairman and CEO of Fairfax.
"Tower is one of the largest insurers in New Zealand and the Pacific Islands, with a long-standing history, good brand recognition and a strong market position.
"The key factors in Fairfax's ability to present an attractive proposal to Tower were the speed at which the transaction could be conducted, the reputation of Fairfax for closing transactions and treating stakeholders fairly," he added.
Michael Stiassny, chairman of Tower, said: "Given the substantial premium to Tower's share price, the certainty provided by the Fairfax Proposal and the support it has received from Salt Funds Management and ACC, the Board determined to unanimously recommend the Fairfax Proposal to all shareholders, in the absence of a superior proposal. Tower's separation strategy will be pursued in the event that the Fairfax Proposal is not successful."
Fairfax is finally set to acquire Allied World, it's recent deal for a sum of $4.9 billion, after Allied failed to find an alternative acquirer in its 30-day 'go-shop' period.
Did you enjoy reading this story? Sign up to our free daily newsletters and get stories like this sent straight to your inbox.
Already registered?
Login to your account
If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content.
For more information on individual annual subscriptions for full paid access and corporate subscription options please contact us.
To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.
For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Elliot Field at efield@newtonmedia.co.uk or Adrian Tapping at atapping@newtonmedia.co.uk
Editor's picks
Editor's picks
More articles
Copyright © intelligentinsurer.com 2024 | Headless Content Management with Blaze